Eurobio Scientific Overview
- Year Founded
-
1962
- Status
-
Public
- Employees
-
290
- Stock Symbol
-
ALERS
- Investments
-
17
- Share Price
-
$29.23
- (As of Thursday Closing)
Eurobio Scientific General Information
Description
Eurobio Scientific operates in the fields of in vitro diagnostics and life sciences. In the Diagnostics sector, it supplies hospital and private diagnostic laboratories with instruments and reagents for medical analyses prescribed by physicians. In the Life Sciences sector, it supplies research laboratories of pharmaceutical groups, biotechnology companies, and public institutions with products required for their R&D programmes, including antibodies that it develops and manufactures. Its products and activities include Transplantation, Oncology, Infectious Diseases, and Life Sciences. The Group generates maximum revenue from France.
Contact Information
Website
www.eurobio-scientific.comCorporate Office
- 7 Avenue de Scandinavie
- ZA de Courtaboeuf
- 91940 Les Ulis
- France
Corporate Office
- 7 Avenue de Scandinavie
- ZA de Courtaboeuf
- 91940 Les Ulis
- France
Eurobio Scientific Stock Performance
As of 12-Nov-2026, Eurobio Scientific’s stock price is $29.23. Its current market cap is $294M with 10.1M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $29.23 | $29.43 | $22.24 - $29.83 | $294M | 10.1M | 3.9K | $0.82 |
Eurobio Scientific Financials Summary
As of 30-Jun-2026, Eurobio Scientific has a trailing 12-month revenue of $201M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 240,724 | 276,223 | 270,539 | 225,520 |
| Revenue | 200,941 | 190,176 | 167,250 | 140,673 |
| EBITDA | 34,327 | 30,064 | 28,118 | 26,473 |
| Net Income | 8,392 | 5,488 | 4,326 | 5,232 |
| Total Assets | 491,662 | 301,590 | 267,602 | 349,670 |
| Total Debt | 17,156 | 18,813 | 10,166 | 111,270 |
Eurobio Scientific Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Eurobio Scientific Comparisons
Industry
Financing
Details
Eurobio Scientific Competitors (16)
One of Eurobio Scientific’s 16 competitors is GSK, a Corporation company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GSK | Corporation | London, United Kingdom | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| Eurofins Genomics Americas | Corporation | Louisville, KY | ||||
| Novartis | Corporation | Basel, Switzerland |
Eurobio Scientific Patents
Eurobio Scientific Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3163370-A1 | Cd74 protein inhibitor compound and its uses | Pending | 18-Jun-2024 | ||
| WO-2025262077-A1 | Cd74 protein inhibitor compound and uses thereof | Pending | 18-Jun-2024 | ||
| EP-3449256-B1 | Anti-il17 antibody | Active | 25-Apr-2016 | ||
| US-11693003-B2 | Anti-il17a autoantibodies for treating or reducing the likelihood of occurrence of bone destruction associated with a chronic autoimmune or inflammatory disease | Active | 25-Apr-2016 | ||
| EP-3449256-A1 | Antiboby anti il17 | Active | 25-Apr-2016 | G01N33/564 |
Eurobio Scientific Signals
Eurobio Scientific Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Eurobio Scientific Investments & Acquisitions (17)
Eurobio Scientific’s most recent deal was a Merger/Acquisition with CareDx (Lab Products Business) for . The deal was made on 30-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CareDx (Lab Products Business) | 30-Jun-2026 | Merger/Acquisition | Diagnostic Equipment | ||
| Voden Medical Instruments (Life Science Unit) | 01-Jul-2025 | Merger/Acquisition | Distributors (Healthcare) | ||
| Quimark | 01-Mar-2025 | Merger/Acquisition | Distributors (Healthcare) | ||
| Myriad Genetics (EndoPredict Business Unit) | 01-Aug-2024 | Merger/Acquisition | Diagnostic Equipment | ||
| Alpha Biotech (Distributors) | 03-Jan-2024 | Merger/Acquisition | Distributors (Healthcare) |
Eurobio Scientific ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Eurobio Scientific Exits (1)
Eurobio Scientific’s most recent exit was on 20-Dec-2006 from RedPath Integrated Pathology. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| RedPath Integrated Pathology | 20-Dec-2006 | Completed |
|
Eurobio Scientific Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| GenDx | Utrecht, Netherlands | 2005 | |
| Quimark | Milan, Italy | 2000 | |
| Pathway Diagnostics (UK) | Dorking, United Kingdom | 1999 | |
| GenBio | San Diego, CA | 1994 | |
| TECOmedical (Other Devices and Supplies) | Sissach, Switzerland | 1984 |
Eurobio Scientific FAQs
-
When was Eurobio Scientific founded?
Eurobio Scientific was founded in 1962.
-
Where is Eurobio Scientific headquartered?
Eurobio Scientific is headquartered in Les Ulis, France.
-
What is the size of Eurobio Scientific?
Eurobio Scientific has 290 total employees.
-
What industry is Eurobio Scientific in?
Eurobio Scientific’s primary industry is Biotechnology.
-
Is Eurobio Scientific a private or public company?
Eurobio Scientific is a Public company.
-
What is Eurobio Scientific’s stock symbol?
The ticker symbol for Eurobio Scientific is ALERS.
-
What is the current stock price of Eurobio Scientific?
As of 12-Nov-2026 the stock price of Eurobio Scientific is $29.23.
-
What is the current market cap of Eurobio Scientific?
The current market capitalization of Eurobio Scientific is $294M.
-
What is Eurobio Scientific’s current revenue?
The trailing twelve month revenue for Eurobio Scientific is $201M.
-
Who are Eurobio Scientific’s competitors?
GSK, Roche, AbbVie, Eurofins Genomics Americas, and Novartis are some of the 16 competitors of Eurobio Scientific.
-
What is Eurobio Scientific’s annual earnings per share (EPS)?
Eurobio Scientific’s EPS for 12 months was $0.82.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process